First-trimester combined screening for trisomy 21 with different combinations of placental growth factor, free ß-human chorionic gonadotropin and pregnancy-associated plasma protein-A.

Kagan, K O; Hoopmann, M; Abele, H; Alkier, R; Lüthgens, K

Kagan, K O; Hoopmann, M; Abele, H; Alkier, R; Lüthgens, K.

Affiliation

Kagan KO; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen, Germany. KOKagan@gmx.de

Ultrasound Obstet Gynecol ; 40(5): 530-5, 2012 Nov.

Article in En | MEDLINE | ID: mdl-22611005

Subject(s)

Down Syndrome/blood; Pregnancy Proteins/blood; Pregnancy-Associated Plasma Protein-A/metabolism; Adult; Case-Control Studies; Chorionic Gonadotropin, beta Subunit, Human/blood; Female; Humans; Nuchal Translucency Measurement; Placenta Growth Factor; Pre-Eclampsia/blood; Pregnancy; Pregnancy Trimester, First; Prenatal Diagnosis; Regression Analysis; Risk Factors; Statistics, Nonparametric

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pregnancy-Associated Plasma Protein-A / Pregnancy Proteins / Down Syndrome Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Female / Humans / Pregnancy Language: En Journal: Ultrasound Obstet Gynecol Journal subject: DIAGNOSTICO POR IMAGEM / GINECOLOGIA / OBSTETRICIA Year: 2012 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google